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Abstract:
Introduction:
Couples’ voluntary HIV counseling and testing (CHTC) is an HIV risk reduction strategy not widely available in the US.
Methods:
We assessed willingness to participate in CHTC among US HIV-infected clinic patients via tablet-based survey and among HIV-
negative persons with HIV-infected partners in care via mixed-method phone interviews.
Results:
Most  of  the  N=64  HIV-infected  partners  surveyed  were  men  (89%),  on  antiretroviral  treatment  (ART)  (92%),  and  many  self-
identified homosexual (62%). We observed high levels of willingness to participate in CHTC (64%) among HIV-infected partners.
Reasons for not wanting to participate included perceived lack of need (26%), desire to self-disclose their status (26%), and fear of
being asked sensitive questions with their partner present (17%). HIV-infected partners were interested in discussing ART (48%),
other sexually transmitted infections (STIs) (44%), and relationship agreements like monogamy (31%) during CHTC sessions. All
N=15 HIV-negative partners interviewed were men, most identified as homosexual (73%), and about half (54%) reported consistent
condom use with HIV-infected partners. We observed high levels of willingness to participate in CHTC (87%) among HIV-negative
partners,  who were  also  interested  in  discussing ART (47%),  other  STIs  (47%),  mental  health  services  (40%),  and relationship
agreements (33%). Most negative partners (93%) indicated that they believed their HIV-infected partner was virally suppressed, but
in the event that they were not, many (73%) were willing to take pre-exposure prophylaxis (PrEP).
* Address correspondence to this author at the Department of Epidemiology School of Public Health, Emory University 1518 Clifton Road NE, 4011,
Atlanta, GA 30322, Georgia, USA; Tel: +001 404 727 9088; E-mail: kmwall@emory.edu
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Conclusion:
These results indicate that CHTC for serodiscordant couples is acceptable and should emphasize aspects most pertinent to these
couples, such as discussion of ART/PrEP, STIs, and relationship agreements.
Keywords:  Acceptability,  combination  prevention,  couples’  voluntary  HIV  counseling  and  testing,  discordant  couples,  HIV
prevention, United States.
INTRODUCTION
Couples’ voluntary HIV counseling and testing (CVCT, or more commonly CHTC in the United States) is a couple-
level HIV testing intervention that includes HIV testing, facilitated serostatus disclosure and HIV prevention counseling
with discussion of sexual agreements, condom use, and linkage to care [1]. CHTC is an evidence-based intervention
shown  primarily  in  high  prevalence  settings  in  Africa  to  decrease  rates  of  unprotected  sex,  sexually  transmitted
infections, and HIV transmission between heterosexual couples [2 - 6]. There are no published data on the efficacy or
effectiveness of CHTC to decrease HIV transmission in same-sex couples; however, CHTC has been demonstrated to
be acceptable to men who have sex with men (MSM) couples in the United States [7 - 9]. Additionally, high levels of
undiagnosed serodiscordance have been observed in this population [10].
The 2012 World Health Organization “Guidance on Couples HIV Testing and Counselling Including Antiretroviral
therapy for Treatment and Prevention in Serodiscordant Couples” recommends that CHTC be offered to all couples
regardless of serostatus or gender and highlights the potential benefit of CHTC for discordant couples to increase uptake
and adherence to antiretroviral  treatment  (ART) amongst  other  health services [11].  Though most  of  the evidences
driving these recommendations come from studies of heterosexual couples in sub-Saharan Africa, the importance of this
intervention for other high-risk populations in the United States and other countries is recognized [12].
In the United States, CHTC has yet to be widely implemented in testing facilities, and CHTC is not available as a
standard service for couples of all genders or sexual orientations in most cities. The safety and acceptability of this
service for MSM has been evaluated in multiple community-based testing facilities in the United States [9, 13, 14].
These services recruit from the general population and have been successful in identifying new prevalent positives and
discordant couples [10].
Less data supporting CHTC effectiveness among heterosexual couples in the United States have been collected,
with the exception of studies among drug-using couples [15 - 17] and African American discordant couples [18 - 21].
Few studies have assessed the acceptability of this service among the general heterosexual population, with one internet
survey of 526 HIV-negative and HIV-infected respondents indicating that about half of respondents were willing to
participate,  with  women  being  more  likely  than  men.  Low  HIV-risk  perception  was  the  main  reason  for  lack  of
willingness to participate in the service [22, 23].
No current data exists on the acceptability of CHTC among HIV-infected clinic patients, heterosexual or MSM, who
are either newly diagnosed or already established in care. Additionally, the willingness of partners of HIV-negative
persons to participate in CHTC with their positive partners has not been evaluated. Studies have demonstrated that main
partners  are  the  source  of  the  majority  of  infections  in  multiple  settings  [24,  25].  High  levels  of  undiagnosed
serodiscordance and the benefits of CHTC in reducing sexual risk behavior [10] highlight the need for increasing the
availability of CHTC services.
Offering CHTC for known HIV-infected persons in care and their partners,  whether MSM or heterosexual,  is  a
potentially high impact strategy to 1) identify discordant couples and reduce sexual risk behaviors among these couples,
where the majority of HIV transmissions occur [6], 2) identify new positives, 3) facilitate partner disclosure for known
HIV-infected persons in care, 4) increase treatment adherence for all eligible HIV-infected partners, and 5) identify
couples eligible for pre-exposure prophylaxis (PrEP) demonstration projects and use [11]. PrEP is a biomedical HIV
prevention intervention in which HIV-negative individuals at risk for HIV acquisition take antiretroviral medications to
prevent seroconversion following HIV exposure. The Centers for Disease Control and Prevention recommends PrEP for
all HIV-negative individuals in serodiscordant relationships [26].
The objectives of this study were to determine the willingness of known HIV-infected patients already engaged in
care to participate in CHTC with their sexual partners. We also evaluated how HIV-negative or serostatus unknown
partners of such HIV-infected patients in care support the health of their HIV-infected partners, their willingness to
participate in CHTC with their known positive partners, and their willingness to take PrEP in the event that they were
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eligible and their positive partners were not virally suppressed.
METHODS
Survey Participants  and Recruitment  We recruited  participants  from the  Emory Midtown Infectious  Disease
Clinic in Atlanta, Georgia over three weeks in March of 2014. Flyers describing the nature of the study were given to
clients  attending  HIV  clinic  services  at  a  scheduled  appointment  time  by  the  clinic  intake  manager  at  check-in.
Interested patients were referred to study staff who were present in the waiting room. These study staff explained the
nature of the study and provided participants with self-administered iPad surveys which included eligibility screening
questions, an informed consent, a short video explaining CHTC, and survey measures. Eligible participants were at least
18 years of age, self-reported HIV-infected, and had at least one sexual partner in the past 12 months. Participants who
chose not to consent or who were not eligible were not able to proceed to the survey measures. Participants received a
$5 Target gift card for completion of the survey.
Survey Measures The survey was hosted on a HIPAA-compliant server by SurveyGizmo (Boulder, CO) and could
be  completed  in  15-20  minutes.  An  option  to  refuse  to  answer  any  sensitive  question  was  included.  No  names  or
identifiers  were  collected.  Demographic  characteristics  included  age,  race,  gender  identity,  sexual  orientation,
education,  insurance  status,  income,  and  ART  status.  Clients  with  main  sexual  partners  (defined  as  a  partner  the
participant  felt  committed  to  above  other  sexual  partners)  provided  information  on  the  length  of  that  relationship,
partner race, partner HIV status, use of condoms with main partners, main partner knowledge of the participants HIV-
infected  status,  questions  about  disclosure,  partner  facilitated  HIV  management,  and  sexual  agreements.  Similar
questions were asked about other/casual partners. CHTC-related questions used in previous willingness surveys [9, 13,
27, 28] included willingness to participate with a partner, who participants would use the service with (main and/or
casual  partners),  reasons  for  getting  tested  together,  and  other  services  that  would  be  of  interest  during  a  couples’
counseling session.
Survey  Analyses  The  online  survey  was  accessed  via  a  secure,  password-protected  Emory  wireless  internet
connection.  Encrypted  data  from  the  online  survey  was  stored  on  a  secure,  HIPAA-compliant  server  at  the
SurveyGizmo©  servers  in  Boulder,  Colorado.  Descriptive  statistics  were  used  (counts  and  percentages)  to  describe
respondent demographic data stratified by willingness to participate in CHTC (likely/very likely versus unlikely/don’t
know/no opinion). Measures related to couples’ testing and measures related to the subset of respondents with main
partners are presented using descriptive statistics.
Mixed-Method  Interview  Participants  and  Recruitment  To  recruit  HIV-negative  partners  of  HIV-infected
clients, clinicians at Emory Midtown Infectious Disease Clinic distributed flyers along with a 2-page information sheet
containing the elements of an informed consent document to their eligible HIV-infected clients. Eligible clients were
those who were 18 years or older who had an HIV negative/unknown sexual partner 18 years or older and who had
already disclosed to this partner. Eligible positive partners were instructed to give the flyer and information sheet to
their  eligible  HIV  negative/unknown  partner.  The  flyer  contained  information  on  how  to  contact  the  study  PI  to
participate in a 30 minute mixed-method phone interview at the time of their choice. Partners desiring to participate
called the study PI and were read an oral consent script. Verbally consenting participants were asked study eligibility
questions (aged 18 or over,  sexually active with the HIV-infected partner in care at the Emory Midtown Infectious
Disease  Clinic  in  the  past  12  months,  HIV-/serostatus  unknown),  and  eligible  participants  were  interviewed.  All
participants were interviewed by the first author. Participants received a $20 Target or Wal-Mart gift card which was
either mailed or emailed to the study participant at their discretion.
Mixed-Method Interview Content Interview information was entered into a secure, HIPAA-compliant, password-
protected Emory database. Data was accessed for monitoring study enrollment and data quality several times weekly,
through a secure access portal. Once eligible study participants consented to participate over the phone, participants
were  interviewed  by  phone  by  the  first  author.  The  information  collected  from  participants  included  demographic
characteristics such as gender, age, race, educational attainment, insurance status and household income. Participants
were also asked to provide information on their HIV-infected partner which included questions regarding how long they
had been in a relationship with their HIV-infected partner, gender, race, condom use in the relationship and current
agreements about sexual encounters outside of the relationship. The CHTC related questions addressed how participants
helped managed their partner’s HIV, willingness to participate in CHTC related services, reasons why they and their
partner would and would not get tested together and reasons they would and would not take pre-exposure prophylaxis
medication if their HIV-infected partner were not virally suppressed.
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Mixed-Method Interview Analyses  Descriptive  statistics  were  used  (counts  and  percentages)  to  describe  both
respondent and partner demographic data. Data pertaining to CHTC services was stratified categorically (likely/very
likely/unlikely/don’t  know/no  opinion).  Three  co-authors  reviewed  the  open-ended  responses  to  the  qualitative
questions to identify common themes. Respondent statements representing the most commonly voiced positive and
negative responses are presented.
ETHICS
This study was determined to be exempt by the Emory University Institutional Review Board.
RESULTS
HIV+ participant survey: Demographics and willingness to participate in CHTC (Table 1)
Table 1. Demographic characteristics by willingness to participate in CVCT among HIV+ participants.
Total (N = 64)
Likely or very likely to
participate in CVCT
(N = 41)
Unlikely/Don't know/No
opinion (N = 23) 1
N/mean (%, SD) N/mean (%, SD) N/mean (%, SD)
Age (mean, SD) 42.3 (10.4) 40.5 (9.5) 45.7 (11.2)
Gender
Man 57 (89) 36 (88) 21 (91)
Woman 7 (11) 5 (12) 2 (9)
Race
Black or African American 49 (78) 32 (80) 17 (74)
White 14 (22) 8 (20) 6 (26)
Sexual orientation
Heterosexual 12 (19) 8 (20) 4 (18)
Homosexual 39 (62) 27 (66) 12 (55)
Bisexual 9 (14) 6 (15) 3 (14)
Don't know/Other 3 (5) 0 (0) 3 (14)
Transgender
Yes 4 (6) 3 (7) 1 (5)
No 59 (94) 38 (93) 21 (95)
Highest level of education
Some high school or less than high school 4 (6) 3 (7) 1 (5)
High school diploma or GED 13 (21) 9 (22) 4 (18)
Some college, Associate's degree, and/or Technical School 29 (46) 17 (41) 12 (55)
College, post graduate, or professional school 17 (27) 12 (29) 5 (23)
Insurance2
Private health insurance or HMO 33 (52) 22 (54) 11 (48)
Medicaid 11 (17) 7 (17) 4 (17)
Medicare 13 (20) 9 (22) 4 (17)
Out of pocket 3 (5) 3 (7) 0 (0)
Ryan White 13 (20) 9 (22) 4 (17)
Don't know/Other 7 (11) 3 (7) 4 (17)
Household income
0 to $19,999 30 (48) 18 (44) 12 (55)
$20,000 to $39,999 15 (24) 10 (24) 5 (23)
$40,000 to $74,999 9 (14) 6 (15) 3 (14)
$75,000 or more 7 (11) 5 (12) 2 (9)
Don't know 2 (3) 2 (5) 0 (0)
Current antiretroviral medication use
Yes 58 (92) 38 (93) 20 (91)
No 5 (8) 3 (7) 2 (9)
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Total (N = 64)
Likely or very likely to
participate in CVCT
(N = 41)
Unlikely/Don't know/No
opinion (N = 23) 1
N/mean (%, SD) N/mean (%, SD) N/mean (%, SD)
Would  you  be  interested  in  discussing  any  of  the  following  services
during a counseling session with a sex partner?2
Anti-retroviral therapy (ART) 31 (48) 25 (61) 6 (26)
Family planning/birth control 4 (6) 3 (7) 1 (4)
Other sexually transmitted infections (STIs) 28 (44) 22 (54) 6 (26)
Injection drug use 8 (13) 6 (15) 2 (9)
Health post-incarceration 12 (19) 9 (22) 3 (13)
Relationship status (monogamy, "open," etc.) 20 (31) 15 (37) 5 (22)
Other 2 (3) 2 (5) 0 (0)
None of the above 22 (34) 8 (20) 14 (61)
Who do you think you would use this service with?3
My main partner -- 34 (83) --
Both my main partner and other partners -- 6 (15) --
Neither my main partner or other partners -- 1 (2) --
What are the reasons why you and your main sex partner would not
get tested together and get your results back together?2 , 4
Afraid my partner might be positive -- -- 3 (13)
Don't need to be tested -- -- 6 (26)
My partner  would not  want  to be tested together,  even if  I  wanted to be
tested together -- -- 2 (9)
I don't want my partner to know my HIV status -- -- 0 (0)
The counselor could ask me questions that I wouldn't want to answer with
my partner there -- -- 4 (17)
I am in a monogamous relationship -- -- 1 (4)
I don't want to know my partner's HIV status -- -- 1 (4)
I would tell my partner myself -- -- 7 (30)
My partner is not at risk for HIV -- -- 2 (9)
Would be hard to schedule time together -- -- 2 (9)
Some other reason -- -- 4 (17)
1. p-values for differences between likely and unlikely groups all non-significant (p>=0.05) from Fisher exact tests.
2. Participants were asked to select all that apply.
3. Only asked of participants who reported being likely or very likely to participate in CVCT.
4. Only asked of participants who reported being unlikely/don’t know/no opinion to participate in CVCT
During the two week recruitment, N=107 HIV clinic patients attending a clinic visit were provided flyers while
waiting for their appointment and agreed to participate. Of those 107, 31 were disqualified because they had not had sex
in the past year, and 12 were not eligible because they had not previously tested HIV-infected.
Of the N=64 HIV-infected respondents in the analysis, most were men (89%), black or African American (78%),
self-identified as homosexual (62%), and were on antiretroviral medication (92%). Our sample was relatively educated,
with 73% of participants reporting some college or higher. Approximately half of participants reported having private
health insurance or HMO; Medicaid, Medicare, and Ryan White were each used by a roughly one-fifth of respondents.
Just under half of participants reported a before-tax household income from all sources of less than $20,000.
Of all  respondents,  41 (64%) said that  they were likely or  very likely to  participate  in  CHTC with their  sexual
partner, 15 (23%) reported that they did not know, and 8 (13%) reported that they were unlikely or very unlikely to
participate in CHTC. The majority (83%) reported that if they were to use the service they would use it with their main
partner (defined as someone you feel committed to above all others), and 15% would use the service with main and
casual/other sexual partners.
Among respondents, 23 (36%) who reported that they were unlikely, did not know, or had no opinion if they would
participate in CHTC with their sexual partner, 3 (13%) reported that they were afraid their partner would be positive, 6
(26%) reported that they do not need to be tested, 7 (17%) reported that the counselor could ask them questions that
they wouldn’t want to answer with their partner there and 6 (26%) reported that they would rather learn their own HIV
status first, then tell their partner.
(Table ) contd.....
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HIV+ participant survey: Main sexual partners (N=33) (Table 2)
Table 2. Characteristics of main partners of HIV-positive respondents.
  Total (N = 33)
  N/mean (%, SD)
Main partner age (mean, SD) 39.2 (11.1)
Length of relationship  
Less than 3 months 3 (9)
3-6 months 4 (12)
7-12 months 4 (12)
More than 12 months 22 (67)
Main partner gender  
Male 28 (85)
Female 5 (15)
Main partner race  
Black or African American 27 (82)
White 6 (18)
Main partner HIV status  
Positive 19 (58)
Negative 11 (33)
Don't know 3 (9)
Condom use frequency with main partner during vaginal or anal sex  
Never/Rarely 11 (34)
Occasionally/Most of the time 7 (22)
Always 14 (44)
Condom use frequency with main partner during vaginal or anal sex2  
Never/Rarely 4 (29)
Occasionally/Most of the time 1 (7)
Always 9 (64)
Does main partner know you are HIV positive?  
Yes 32 (97)
No 1 (3)
How did the conversation go when you told them that you are HIV+?  
Average 5 (16)
Well 26 (84)
What happened after you told them your HIV status?  
We stopped having sex 2 (6)
We continued having sex and always used condoms 13 (41)
We continued having sex and used condoms sometimes 11 (34)
We continued having sex and never used condoms 6 (19)
Looking back, how do you feel now about having told them your HIV status?  
I am glad I shared my HIV status 27 (84)
I regret having shared my HIV status 2 (6)
Don't know/no strong feelings 3 (9)
How does your main partner help you manage your HIV?1  
Makes sure I take my medicine 17 (52)
Comes with me to the clinic 5 (15)
Helps me try to stay healthy 17 (52)
Other 2 (6)
He/she doesn't help me manage my HIV 4 (12)
   
Current sexual agreement with main partner  
Neither of us can have any sex with an outside partner 22 (67)
We can have sex with outside partners, without any conditions or restrictions 0 (0)
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  Total (N = 33)
  N/mean (%, SD)
We can have sex with outside partners, but with some conditions or restrictions 5 (15)
We do not have an agreement 3 (9)
Don’t know 3 (9)
1. Participants were asked to select all that apply.
2. Among HIV-positive respondents with HIV serostatus negative/unknown partners
Of the N=33 HIV-infected respondents with a main partner, the majority (67%) were in relationships longer than 12
months. Most partners were men (85%), and were black or African American (82%). A third (33%) reported that their
main partner was HIV-negative, and roughly a tenth (9%) reported that they did not know their partner’s HIV status.
Nearly all (97%) of respondents with main partners reported having disclosed their positive HIV status; the majority
(84%) of those indicated that the conversation went well at the time of disclosure and most (84%) reported they were
glad they shared their  status.  Most  respondents  indicated that  after  telling their  partner  their  status,  they continued
having  sex  and  used  condoms  always  (41%)  or  sometimes  (34%).  The  plurality  (44%)  of  respondents  said  they
currently always used condoms with their main partner during anal or vaginal intercourse; approximately a fifth (22%)
reported using condoms with their main partner sometimes, and a third (34%) reported using condoms with their main
partner rarely or never. Roughly half (52%) of respondents indicated that their partner helps them to manage their HIV
by making sure they take their medication and helping them to stay healthy. Most (67%) participants indicated that they
had an agreement with their main partner to not have sex with outside partners. Under a fifth (18%) of respondents said
that they did not have an agreement or did not know of an agreement with their main partner regarding outside partners.
HIV- partner mixed-method interviews: Quantitative findings (Tables 3 - 4)
Table 3. Demographic and relationship characteristics of HIV-negative respondents in serodiscordant relationships.
Total (N = 15)
N (%)
Gender
Male 15 (100)
   
Gender of sex partners, past 12 months
Men 13 (86)
Women 1 (7)
Both men and women 1 (7)
Race1
Black or African American 10 (67)
White 3 (20)
Other 2 (13)
Sexual Orientation
Heterosexual 1 (7)
Homosexual 11 (73)
Bisexual 2 (13)
Other 1 (7)
Don't know 0 (0)
Education
Less than high school 0 (0)
Some high school 0 (0)
High school diploma or GED 4 (27)
Some college, Associate's degree, and/or Technical School 6 (40)
College, post graduate, or professional school 5 (33)
Health Insurance Status1
Private health insurance or HMO 9 (60)
Medicaid 1 (7)
Medicare 4 (27)
Out of pocket 2 (13)
(Table ) contd.....
8   The Open AIDS Journal, 2016, Volume 10 Wall et al.
Total (N = 15)
N (%)
Ryan White 0 (0)
Don't know 0 (0)
Other 0 (0)
Household Income
0 to $19,999 6 (41)
$20,000 to $39,999 2 (13)
$40,000 to $74,999 3 (20)
$75,000 or more 2 (13)
Don't know 2 (13)
Length of Relationship
Less than one month 0 (0)
1-2 months 0 (0)
3-6 months 0 (0)
7-12 months 1 (7)
More than 12 months 14 (93)
Partner Gender
Male 14 (93)
Female 1 (7)
Partner Transgender  (0)
Yes 1 (7)
No 14 (93)
Partner Race1
Black or African American 10 (67)
White 4 (27)
Other 1 (6)
Condom Use with Partner
Never 1 (7)
Rarely 2 (13)
Occasionally 2 (13)
Most of the time 2 (13)
Always 8 (54)
Current Relationship Agreement
Neither of us can have any sex with an outside partner 12 (80)
We can have sex with outside partners, without any conditions or restrictions 0 (0)
We can have sex with outside partners, but with some conditions or restrictions 1 (7)
We do not have an agreement 3 (20)
Don't know 0 (0)
  Mean, SD
Age 48.1 (10.1)
1. Participants were asked to report all that apply.
Of the N=15 HIV-negative respondents with a positive partner, the majority (93%) were in a relationship for more
than  12  months.  Most  partners  were  men  (86%),  identified  as  black  or  African  American  (67%)  and  considered
themselves  to  be  homosexual  (73%).  In  regards  to  educational  attainment,  most  respondents  had  completed  some
college, obtained an Associate’s degree, and/or attended Technical school (40%); attended college, post graduate, or
professional school (33%); or obtained a high school diploma or GED (27%). Many respondents paid for healthcare
services with private health insurance (60%) and had a household income less than $20,000 before taxes (41%).
Most respondents reported that their positive partner was male (93%) and considered themselves to be black or
African American (67%). About half of respondents (54%) reported they always use condoms when having vaginal or
anal sex with their main partner. When asked about any current agreements with their positive partner regarding sexual
encounters outside of the relationship, the majority (80%) reported that neither of them can have sex with an outside
partner, while 20% reported that they do not have an agreement.
(Table ) contd.....
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Of all respondents (15), the majority (60%) reported that they would be very likely to participate in CHTC services
with their HIV-infected partner if it was available to them. Most (60%) also reported that there would be no reason not
to participate in CHTC services with their positive partner. Most respondents were interested in both the discussion of
anti-retroviral therapy (47%) and other STIs (47%) during a CHTC session with their partner. When asked about being
aware of whether their partner was virally suppressed, the majority (93%) reported that their partner was suppressed.
Most respondents reported that they would take pre-exposure prophylaxis (PrEP) medication if their partner were not
virally suppressed. When asked about reasons why they would not take PrEP, the majority (53%) reported a concern
regarding side effects. When asked why they would be open to taking PrEP, most respondents (80%) asserted that they
wanted to stay healthy/prevent acquiring HIV.
HIV- partner mixed-method interviews: qualitative findings
Fifteen mixed-method interviews of HIV-negative persons with HIV-infected partners were completed.  Though
participants were given the opportunity to provide additional comments concerning CHTC, PrEP and/or other related
matters, the majority only discussed PrEP. The majority (13/15) expressed an interest in the use of PrEP medication. Of
those who were interested, the common themes focused on being willing to try a new treatment based on either their
own health condition or their partner’s viral load status. Participants who mentioned that they were not interested in
PrEP declared that they thought PrEP was an irresponsible use of medication and could perhaps lead to increased risky
sexual behaviors and unprotected sex.
Positive Views A number of positive views of PrEP were expressed by the participants. When considering a partner
who was either recently diagnosed with HIV or who was not virally suppressed, HIV-negative participants expressed a
high level of interest in PrEP. One participant noted that he is always looking for new and better treatments and is
willing to try new things. Another participant who had previously undergone cancer treatment speculated that PrEP
could  not  be  worse  than  chemotherapy;  he  also  noted  that  due  to  a  weakened  immune  system  he  is  particularly
concerned with preventing seroconversion and would definitely take PrEP.
Negative Views Negative views about PrEP primarily focused on the use of antiretroviral medication as a means for
prophylaxis. One participant noted that it “seems like a very irresponsible use of drugs.” Another participant expressed
concern about risk compensation and increasing rates of condomless sex. In this participant’s opinion, taking PrEP for
the purposes of engaging in casual sex is “a misuse of the drug.” Finally, one respondent felt that there was too much
focus on HIV and that this is detracting focus from other sexual risks such as transmission of other STIs. He noted that
he is more worried about the other STIs that he could acquire from risky sexual encounters than HIV seroconversion.
DISCUSSION
We sought to assess the willingness of HIV-infected patients already engaged in care to participate in CHTC with
their HIV-negative or serostatus unknown sexual partners. Among the sexual partners of these patients, we sought to
assess the ways in which they support the health of their HIV-infected partner, their willingness to participate in CHTC
with their known positive partner, and their willingness to take PrEP. Overall, the majority of participants, both HIV-
infected (64%) and HIV-negative (87%) expressed willingness to participate in CHTC.
It is important to distinguish between the importance of CHCT for identifying discordant couples who did not know
they were discordant and the added value of CHCT even after disclosure has occurred. Among HIV-infected partners
who were unsure or unwilling to participate in CHTC, the main reasons for not wanting to participate in CHTC was a
perceived lack of  a  need (26%).  This  could be due to the relatively high levels  of  disclosure reported by the HIV-
infected participants in the current study, which suggest that self-disclosure may already be occurring outside of the
context of CHTC within stable relationships. Low perceived risk has been found to be a barrier in other studies [22, 23]
and highlights the significance of emphasizing the other benefits of CHTC beyond serostatus disclosure (such as those
identified  by  the  participants  themselves,  including  discussion  of  care  for  positive  partners,  other  STI  prevention,
discussions about ART/PreP, and relationship agreements), as well as the opportunity for HIV-negative/unknown status
partners in known serodiscordant relationships to be regularly tested for HIV.
CHTC can also be used to discuss prevention of transmission - regular condom use was low in this analytic group,
and  HIV-negative  partners  commonly  reported  believing  their  HIV-positive  partners  to  be  virally  suppressed.  The
confidence that may come with perceived viral suppression could be addressed during CHTC. These discussions are
important in reducing the transmission of HIV to the HIV-negative partner and reducing condomless sex with outside
partners and the possibility of superinfection. The cumulative probability of HIV transmission has been estimated to be
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13% in heterosexual couples and 76% in same-sex male couples over a 10-year period when relying on condoms alone
[29]. When relying on antiretroviral therapy (ART) for the HIV-infected partner alone the 10-year risk is estimated to
be 3% and 25% for heterosexual and same-sex male couples, respectively [29]. Regular CHTC could be an important
component  in  sustaining  risk  reduction  practices  in  serodiscordant  couples.  Further,  though  we  did  not  recruit
concordant positive couples in this study, it could be valuable to use CHTC to provide education about the need to
continue to use condoms to prevent ART resistance and other STI’s.
Another frequently cited reason among HIV-infected partners for not participating in CHTC was that the counselor
might ask questions that the participant would not want to answer in the presence of their partner (17%). This important
finding  highlights  the  need  for  promotional  messaging  around  the  fact  that  unwanted  disclosure  of  other
sensitive/personal  information  is  not  a  part  of  CHTC  programs.  CHTC  focuses  on  future  relationship  goals  and
expectations rather than asking participants to have potentially uncomfortable discussions about past behavior [8].
Table 4. Opinions about CVCT and PrEP willingness among HIV-negative participants in serodiscordant relationships.
Total (N = 15)
N (%)
How do you help your partner manage their HIV?1
Make sure they take their medicine 12 (80)
Come to the clinic 12 (80)
Help them try to stay healthy 12 (80)
I don't help them manage their HIV 1 (7)
If couples HIV testing was available to you (where you and a sex partner got tested together and received your results and
counseling together), how likely would be to participate?
Very unlikely 1 (7)
Unlikely 1 (7)
I don't know/no opinion 0 (0)
Likely 4 (26)
Very likely 9 (60)
What are the reasons why you and your partner would not get tested together and get your results back together? 1
Don't need to be tested 1 (7)
My partner would not want to be tested together, even if I wanted to be tested together 1 (7)
I don't want my partner to know my HIV status 0 (0)
The counselor could ask me questions that I wouldn't want to answer with my partner there 0 (0)
I am in a monogamous relationship 0 (0)
I don't want to know my partner's HIV status 1 (7)
Afraid I might be positive 1 (7)
I would rather learn my own status first, then tell my partner 1 (7)
Would be hard to schedule time together 0 (0)
No reason not to 9 (60)
Would you be interested in discussing any of the following services during a counseling session with a sex partner?1
Anti-retroviral therapy (ART) 7 (47)
Family planning/birth control 0 (0)
Other sexually transmitted infections (STIs) 7 (47)
Injection drug use 3 (20)
Non- injection drug use 3 (20)
Health post-incarceration 4 (27)
Relationship status (monogamy, "open," etc.) 5 (33)
Alcohol use 4 (27)
Mental health services 6 (40)
None of the above 5 (33)
Do you know if your partner is virally suppressed?
Yes, they are 14 (93)
No, they are not 1 (7)
Don't know 1 (7)
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Total (N = 15)
N (%)
If  your  partner  were  not  virally  suppressed  (meaning  that  their  HIV  virus  was  high  and  capable  of  onward  sexual
transmission) would you take Pre-exposure prophylaxis until your partner started medication and had a low viral count
(about 3 months)?
Very unlikely 4 (27)
Unlikely 0 (0)
I don't know/no opinion 0 (0)
Likely 2 (13)
Very likely 9 (60)
What are the reasons why you would NOT take pre-exposure prophylaxis if your partner were not virally suppressed?
Side effects 8 (53)
Not necessary - we don't/wouldn't have unprotected sex 5 (33)
What are the reasons why you WOULD take pre-exposure prophylaxis if your partner were not virally suppressed?
To stay healthy/prevent acquiring HIV 12 (80)
If we wanted to have unprotected sex 4 (27)
1. Participants were asked to report all that apply.
We observed a high prevalence of serodiscordance among HIV-infected persons with primary sexual partners. Of
HIV-infected patients with a main partner, 42% had a HIV-negative or serostatus unknown main partner. CHTC has the
potential to identify new HIV-infected individuals and serodiscordant couples. The latter are a critical prevention group
- CDC estimates that 14% of HIV-infected people in the United States are unaware of their infection [30], and it has
been estimated that individuals unaware of their infection are 3.5 times more likely to transmit HIV to their sexual
partners [31].
Among HIV-negative partners, willingness to participate in CHTC with their known HIV-infected partners was
even higher, perhaps in part because HIV-negative partners in discordant relationships have higher risk perception -
only 7% of HIV-negative partners reported that a reason to not seek CHTC was that they didn’t need to be tested and
60% did not cite any reason not to test with their positive partner.
HIV-negative  partners  were  similarly  interested  in  discussing  ART  (47%),  other  STIs  (47%),  and  relationship
agreements (33%) during CHTC sessions. One notable difference was that mental health services (40%) were also of
interest. Additionally, the majority of negative partners (93%) indicated that they believed their positive partner to be
virally suppressed, but in the event that they were not, most (73%) were willing to take PrEP. The most common reason
for wanting to take PrEP was to stay healthy and prevent HIV acquisition (80%) followed by the desire to more safely
have unprotected sex (27%). Side effects (53%) and willingness to abstain from sex/use condoms (33%) were reported
reasons to not use PrEP.
This study has limitations. This is a convenience sample of HIV-infected patients from an urban clinic and HIV-
negative and serostatus unknown partners of HIV-infected patients and the participants may not be representative of all
HIV-infected  patients  and  their  partners.  Therefore,  the  generalizability  of  these  results  may  be  limited  to  more
educated MSM. The HIV-infected survey respondents were recruited separately from the HIV-negative and unknown
serostatus mixed-method interview respondents; thus, they do not represent couples. Just under one fifth of respondents
were heterosexual; stratified analyses of heterosexual and MSM might yield different results. Further, because the HIV-
infected participants were recruited from a clinic setting they had been in care for an unknown amount of time. It is
possible that newly diagnosed individuals would be more or less likely to be interested in CHTC or PrEP. The mixed-
method interviews were conducted by phone, so there is the possibility that some participants’ responses were biased
due to social desirability.
Despite  these  limitations,  our  results  indicate  that  CHTC  for  serodiscordant  couples  is  acceptable  and  should
emphasize aspects most pertinent to these couples, such as discussion about ART/PrEP, STIs, relationship agreements,
and how to best support the partner in care. It may be necessary to highlight the benefits of CHTC beyond serostatus
disclosure  to  this  population,  and  dispel  myths  about  what  sensitive  information  may  be  elicited  during  CHTC.
Expansions of CHTC service should consider the needs of known serodiscordant couples in both marketing and service
provision.
(Table ) contd.....
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